Related Experiment Video
Updated: Jul 27, 2026

12:07
NADH Fluorescence Imaging of Isolated Biventricular Working Rabbit Hearts
Published on: July 24, 2012
Naloxone blocks transferred preconditioning in isolated rabbit hearts
E W Dickson1, D J Blehar, R E Carraway
1Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA. dicksone@ummhc.org
Journal of Molecular and Cellular Cardiology
|September 11, 2001
Summary
Cardioprotective factors in heart's coronary effluent can be concentrated and transferred. These factors require opioid receptor activation to protect hearts from injury, suggesting a novel therapeutic pathway.
Area of Science:
- Cardiovascular Physiology
- Ischemic Preconditioning
- Pharmacology
Background:
- Ischemic preconditioning (PC) confers cardioprotective benefits.
- These benefits can be transferred via coronary effluent, suggesting circulating factors.
- The exact nature and mechanism of these transferable factors remain unclear.
Purpose of the Study:
- To concentrate and recover cardioprotective factors from coronary effluent using reverse phase chromatography.
- To investigate the role of opioid receptor activation in the cardioprotection mediated by these transferred factors.
Main Methods:
- Isolated rabbit hearts were perfused with buffer.
- Coronary effluent from ischemic preconditioned (PC) or normoxic hearts was concentrated.
- Hearts were subjected to global ischemia, and infarct size (area of necrosis) was measured.
- The effect of opioid antagonist naloxone on protection was assessed.
Main Results:
- Concentrate from PC hearts significantly reduced infarct size compared to controls.
- Concentrate from normoxic hearts had no protective effect.
- Naloxone abolished the cardioprotective effect of PC concentrate, but not conventional PC.
- Opioid receptor blockade abrogated the transferred cardioprotection.
Conclusions:
- Cardioprotective factors present in coronary effluent can be concentrated and transferred.
- The protective mechanism of these transferred factors critically involves opioid receptor activation.
- This suggests a novel therapeutic strategy targeting opioid receptors for cardiac protection.

